Trial Profile
Efficacy and safety of Tocilizumab treatment in patients with new-onset refractory status epilepticus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Status epilepticus
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2018 New trial record
- 08 Nov 2018 Results published in the Annals of Neurology